Helpful Evrysdi resources

Resources in English

Recursos en Español

Whether you are considering your treatment options, or are already on Evrysdi, the resources below may be useful

Resources in English

Learn More About Evrysdi

Get to know Evrysdi, including an overview of how it works and how it could help.

Talking to Your Doctor About Evrysdi

Use these questions to guide your discussion about Evrysdi with your healthcare provider.

Navigating Insurance and Financial Support Options

Use this guide to better understand potential insurance and financial support options for Evrysdi.

Getting Started on Evrysdi

A step-by-step guide to taking Evrysdi by mouth or feeding tube.

Instructions for Use

Information how to prepare and give Evrysdi through an oral syringe, gastrostomy tube (G-tube), or nasogastric tube (NG-tube).

Recursos en Español

Conozca Evrysdi

Conozca Evrysdi y lea un resumen sobre cómo funciona y cómo podría ayudarle.

Guía rápida sobre seguro de salud y asistencia financiera

Utilice esta guía para comprender mejor las posibles opciones de seguro y apoyo financiero para recibir Evrysdi.

Cómo comenzar con Evrysdi

Una guía paso a paso para tomar Evrysdi por vía oral o a través de una sonda de alimentación.

Instrucciones de Uso

Información e instrucciones para preparar y administrar Evrysdi a través de una jeringa de dosificación oral, sonda de gastrostomía (sonda G) o sonda nasogástrica (sonda NG).

MySMA Support

Obtenga más información sobre MySMA Support, las opciones de apoyo financiero, el envío de recetas y más.

Find a PAL near you

A Partnership and Access Liaison (PAL) can answer your questions about Evrysdi. Get in touch to learn more.

Evrysdi Community Educational Events

Hear people with SMA and parents of children with SMA share their experiences with Evrysdi.

What is Evrysdi?

Evrysdi® (risdiplam) is a prescription medicine used to treat spinal muscular atrophy (SMA) in adults and children 2 months of age and older.


It is not known if Evrysdi is safe and effective in children under 2 months of age.

  • Before taking Evrysdi, tell your healthcare provider about all of your medical conditions, including if you:
    • are pregnant or plan to become pregnant. If you are pregnant, or are planning to become pregnant, ask your healthcare provider for advice before taking this medicine. Evrysdi may harm your unborn baby.
    • are a woman who can become pregnant:
      • Before you start your treatment with Evrysdi, your healthcare provider may test you for pregnancy. Because Evrysdi may harm your unborn baby, your healthcare provider will decide if taking Evrysdi is right for you during this time
      • Talk to your healthcare provider about birth control methods that may be right for you. Use birth control while on treatment and for at least 1 month after stopping Evrysdi
    • are an adult male planning to have children: Evrysdi may affect a man’s ability to have children (fertility). If this is of concern to you, make sure to ask a healthcare provider for advice
    • are breastfeeding or plan to breastfeed. It is not known if Evrysdi passes into breast milk and may harm your baby. If you plan to breastfeed, discuss with your healthcare provider about the best way to feed your baby while on treatment with Evrysdi
  • Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine
  • You should receive Evrysdi from the pharmacy as a liquid that can be given by mouth or through a feeding tube. The liquid solution is prepared by your pharmacist. If the medicine in the bottle is a powder, do not use it. Contact your pharmacist for a replacement
  • Avoid getting Evrysdi on your skin or in your eyes. If Evrysdi gets on your skin, wash the area with soap and water. If Evrysdi gets in your eyes, rinse your eyes with water
  • The most common side effects of Evrysdi include:
    • For later-onset SMA:
      • fever
      • diarrhea
      • rash
    • For infantile-onset SMA:
      • fever
      • diarrhea
      • rash
      • runny nose, sneezing, sore throat, and cough (upper respiratory infection)
      • lung infection
      • constipation
      • vomiting

These are not all of the possible side effects of Evrysdi. For more information on the risk and benefits profile of Evrysdi, ask your healthcare provider or pharmacist.

You may report side effects to the FDA at 1-800-FDA-1088 or You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional Important Safety Information.